Adicet Bio, Inc.
ACET
$8.15
$0.040.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 20.00M | 22.99M | 23.61M | 25.41M | 28.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 113.80M | 122.12M | 120.97M | 126.17M | 126.63M |
| Operating Income | -113.80M | -122.12M | -120.97M | -126.17M | -126.63M |
| Income Before Tax | -108.83M | -116.80M | -115.01M | -118.64M | -117.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -108.83 | -116.80 | -115.01 | -118.64 | -117.32 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -108.83M | -116.80M | -115.01M | -118.64M | -117.32M |
| EBIT | -113.80M | -122.12M | -120.97M | -126.17M | -126.63M |
| EBITDA | -107.76M | -115.73M | -114.44M | -119.62M | -120.13M |
| EPS Basic | -15.03 | -18.10 | -20.22 | -20.87 | -20.66 |
| Normalized Basic EPS | -9.39 | -11.31 | -12.64 | -13.04 | -12.91 |
| EPS Diluted | -15.03 | -18.10 | -20.22 | -20.87 | -20.66 |
| Normalized Diluted EPS | -9.39 | -11.31 | -12.64 | -13.04 | -12.91 |
| Average Basic Shares Outstanding | 32.50M | 27.44M | 22.76M | 22.74M | 22.71M |
| Average Diluted Shares Outstanding | 32.50M | 27.44M | 22.76M | 22.74M | 22.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |